Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1

Vicriviroc in Combination Therapy with an Optimized Regimen for Treatment‐Experienced Subjects: 48‐Week Results of the VICTOR‐E1 Phase 2 Trial

(2010) Jamal Suleiman et al.   JOURNAL OF INFECTIOUS DISEASES

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

(2009) Jerry Polesel et al.   AIDS

Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men

(2009) Robert C Kaplan et al.   AIDS

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients

(2009) Aylin Yilmaz et al.   AIDS

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

(2009) Christina M Marra et al.   AIDS

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

(2009) Pablo Labarga et al.   AIDS

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

(2009) Priscilla Y Hsue et al.   AIDS

Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients

(2009) Gerd Fätkenheuer et al.   AIDS

Continuous antiretroviral therapy decreases bone mineral density

(2009) Birgit Grund et al.   AIDS

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy

(2009) Benoît Marin et al.   AIDS

Incidence and risk factors of HIV-related non-Hodgkin’s lymphoma in the era of combination antiretroviral therapy: a European multicohort study

(2009)   ANTIVIRAL THERAPY

Coronary Aging in HIV‐Infected Patients

(2009) Giovanni Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

Better Adherence with Once‐Daily Antiretroviral Regimens: A Meta‐Analysis

(2009) Jean‐Jacques Parienti et al.   CLINICAL INFECTIOUS DISEASES

Incomplete Peripheral CD4+Cell Count Restoration in HIV‐Infected Patients Receiving Long‐Term Antiretroviral Treatment

(2009) Colleen F. Kelley et al.   CLINICAL INFECTIOUS DISEASES

Effect of HIV‐1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy

(2009) Anna Maria Geretti et al.   CLINICAL INFECTIOUS DISEASES

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial

(2009) Y. Yazdanpanah et al.   CLINICAL INFECTIOUS DISEASES

Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART

(2009) BO Taiwo et al.   HIV MEDICINE

Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome

(2009) NF Önen et al.   HIV MEDICINE

Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases

(2009) Jason V Baker et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression

(2009) Roger J Bedimo et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression

(2009) Weiwei Cao et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

(2009) Todd T Brown et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation

(2009) S. Molina-Pinelo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with

(2009) Silvia Baroncelli et al.   JOURNAL OF CLINICAL VIROLOGY

Cumulative HIV Viremia during Highly Active Antiretroviral Therapy Is a Strong Predictorof AIDS‐Related Lymphoma

(2009) Alexander Zoufaly et al.   JOURNAL OF INFECTIOUS DISEASES

Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+T Cells

(2009) Martyn A. French et al.   JOURNAL OF INFECTIOUS DISEASES

Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection

(2009) Wei Jiang et al.   JOURNAL OF INFECTIOUS DISEASES

Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4+ T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy

(2009) T. P. Brennan et al.   JOURNAL OF VIROLOGY

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

(2009) Marguerite Guiguet et al.   LANCET ONCOLOGY

Interleukin-2 Therapy in Patients with HIV Infection

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

(2009) Mari M. Kitahata et al.   NEW ENGLAND JOURNAL OF MEDICINE

Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa

(2009) A. D. Redd et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

(2009) J. B. Dinoso et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

(2008)   AIDS

Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy

(2008) Giulia Marchetti et al.   AIDS

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

(2008) Jason V Baker et al.   AIDS

High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients

(2008) M. Rodríguez et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System

(2008) Scott Letendre   ARCHIVES OF NEUROLOGY

Antiretroviral Treatment of Adult HIV Infection

(2008) Scott M. Hammer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population

(2008) Krishnan Bhaskaran   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection

(2008) Lin Shen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Antiviral Activity of Single‐Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV‐Infected Adults

(2008) Jeffrey M. Jacobson et al.   JOURNAL OF INFECTIOUS DISEASES

Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection

(2008) Raphael J. Landovitz et al.   JOURNAL OF INFECTIOUS DISEASES

Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy

(2008) Francesca J. Torriani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

(2008)   LANCET

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

(2008) Lin Shen et al.   NATURE MEDICINE

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

(2008) Sharon A. Riddler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

(2008) S. Palmer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

(2007) Peter W. Hunt et al.   JOURNAL OF INFECTIOUS DISEASES